Effects of SGLT2is and Aldosterone Antagonists on Major Adverse Kidney Outcomes in Patients With T2D and CKD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Effects of sodium-glucose cotransporter 2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: a systematic review and network meta-analysis
Diabetes Obes Metab 2022 Jun 16;[EPub Ahead of Print], S Yang, L Zhao, Y Mi, W HeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.